Clinical trials
HIV clinical trials
Below are recruiting hiv clinical trials, each written for real people, not researchers. We’re tracking 611 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05752500Recruiting
Behavior coaching to help older adults with HIV move more
This study tests a tailored behavioral coaching program to increase physical activity in adults age 50+ who have HIV and are currently not very active. It may help you build safer, more routine movement using a Fitbit for tracking.
Minneapolis, MinnesotaAges 50 years+ - NCT06252402RecruitingEarly Phase 1
CAR T cells for HIV: A new immunotherapy study
This trial tests a new type of immune cell, called a CAR T cell, that is designed to target and kill cells infected with HIV. It may help control the virus without needing to take HIV medication all the time.
Duarte, CaliforniaAges 18 years+ - NCT06096324Recruiting
Education and job support for HIV prevention in young adults
This study is testing a program that combines education and job support to help young adults in Baltimore stay healthy and prevent HIV. It aims to see if this combined approach works better than education alone.
Baltimore, MarylandAges 18–24 - NCT07502365Recruiting
Guaranteed income for young adults living with HIV
This study tests whether providing a basic income (no-strings-attached cash payments) can help young people with HIV stay healthy and engaged in care. If you qualify, you would receive regular payments and the research team would track your health over time.
Chicago, IllinoisAges 18–35 - NCT07579741RecruitingPhase 1/Phase 2
Testing JL18008 for HIV Patients Not Recovering Immune Cells
This study tests an experimental drug called JL18008 in people with HIV who have been on stable HIV medications for years but whose immune systems (CD4 cells) haven't recovered as expected. The drug may help boost immune function in these patients.
Beijing, Beijing MunicipalityAges 18–65 - NCT07645287RecruitingPhase 2
New HIV Combination Therapy for People on Biktarvy
This study tests a new HIV medication (GS-3242) combined with lenacapavir against your current Biktarvy regimen. Both are all-oral treatments for people whose HIV is well-controlled.
Beverly Hills, CaliforniaAges 18 years+ - NCT06930508Recruiting
Bringing HIV prevention meds to a family planning clinic
This study looks at offering HIV prevention medicines (PrEP) to patients visiting a family planning clinic. It aims to make it easier for people to access this care alongside their regular visit.
Providence, Rhode IslandAges 16 years+ - NCT07569029RecruitingPhase 1
HIV vaccine with treatment break to boost immune response
This Phase 1 trial tests two new HIV vaccines (DV700P-RNA and DV701B1.1-RNA) combined with a monitored break from HIV medications in people with well-controlled HIV. The goal is to see if this approach safely strengthens the immune system's ability to fight HIV.
Birmingham, AlabamaAges 18–60 - NCT06962592Recruiting
Mentor Moms+ pregnancy alcohol support study
This study tests whether having a mentor mom can help people who are pregnant and have used alcohol recently. It aims to provide support and improve health for both the parent and baby.
Cape Town, Western CapeAges 16 years+ - NCT06880224Recruiting
HIV prevention and treatment for Nigerian youth aged 15-24
This study tests better ways to find and treat HIV in young people (ages 15-24) in Nigeria. It offers either HIV prevention medicine (PrEP) if you are HIV-negative, or HIV treatment if you are newly diagnosed with HIV.
Uyo, Akwa Ibom StateAges 15–24 - NCT06834113Recruiting
Testing pain relief from HIV shot location and virtual reality
This study looks at whether changing where you get your HIV injection (in the buttock area) and using a virtual reality headset during the shot can reduce pain. It is for people whose HIV is well-controlled with the injectable medicines cabotegravir and rilpivirine.
Orléans, LoiretAges 18 years+ - NCT06666309Enrolling by invitation
Study on HIV prevention for people who inject drugs
This study tests different ways to help people who inject drugs stay on PrEP, a daily pill that prevents HIV. It's for people who are HIV-negative and have recently injected drugs.
Barbourville, KentuckyAges 18 years+ - NCT06666530Recruiting
Quality of life for pregnant women with HIV
This study looks at how being pregnant while living with HIV affects your quality of life and the care you receive. It aims to understand your experiences and needs during this time.
ParisAges 18 years+ - NCT06691243RecruitingPhase 2
Testing semaglutide for cocaine use in adults
This study tests if the diabetes drug semaglutide (also used for weight loss) can help reduce cocaine use in adults, including those living with HIV. It's free and lasts about 8 weeks.
Washington D.C., District of ColumbiaAges 18–65 - NCT06203132RecruitingPhase 3
Doravirine vs Dolutegravir for first-time HIV treatment
This study compares two HIV medicines, doravirine and dolutegravir, to see which works better for people who have never taken HIV treatment before. If you qualify, you would be randomly assigned to one of the two medications.
Nova Iguaçu, Rio de JaneiroAges 18 years+ - NCT06056544Enrolling by invitation
HIV prevention support for Black men who have sex with men
This study tests a personalized care coordination program to help Black men who have sex with men stay on HIV prevention. It focuses on men who are new to or have stopped PrEP and want to reduce their HIV risk.
Washington D.C., District of ColumbiaAges 18 years+ - NCT05453513Recruiting
Study how depression and cannabis affect the brain in young adults with HIV
This study looks at brain activity to understand how depression and cannabis use may be linked in young adults living with HIV. It mainly involves questionnaires, mental health screening, and brain scans, which may help researchers better understand risk factors and brain “underpinnings.”
Miami, FloridaAges 18–59 - NCT05143307Enrolling by invitationPhase 1
Follow-up study for adults who received EBT-101 for HIV
This study checks how adults are doing long-term after receiving an HIV treatment called EBT-101 in an earlier study. It helps researchers understand safety and longer-term effects over time.
San Francisco, CaliforniaAges 18 years+ - NCT04553081RecruitingPhase 4
Switching HIV treatment: 2-drug versus 3-drug plan
This trial compares two different HIV treatment plans: keeping you on a 2-drug regimen versus switching to a 3-drug regimen. It’s designed for people whose HIV is well controlled and looks at whether the switch is safe and effective.
GhentAges 18 years+ - NCT02154035Recruiting
Measuring HIV reservoir in Ugandans with suppressed virus
This study in Uganda looks at the HIV 'reservoir' (where the virus hides in the body) in people whose HIV is already well-controlled with medications. It involves blood draws and genetic testing to learn more about the virus.
KalisizoAges 18–49 - NCT00796146Recruiting
Study people newly infected with HIV to learn early changes
This study enrolls adults with a very recent (“acute”) HIV infection to follow them over time and better understand what happens early after infection. Your participation may help researchers improve how acute HIV is detected and managed.
Bangkok, BangkokAges 18 years+ - NCT02437526Enrolling by invitation
Testing an HIV treatment pause to see if cure is possible
This study looks at whether some people with HIV can keep the virus controlled even if they temporarily stop HIV medicines (an “analytic treatment interruption”). If you qualify, it may help researchers learn what it would take for an HIV cure.
Rochester, MinnesotaAges 18 years+ - NCT01202305Recruiting
Lymph node biopsies to study HIV in different patients
This study uses a small tissue sample from an often-accessible lymph node to learn how HIV affects the body. It may help researchers understand why some people control HIV better than others.
San Francisco, CaliforniaAges 18–70 - NCT06928090Enrolling by invitation
HIV trial testing two-med combo for first-time treatment
This trial studies a two-drug pill (DTG/3TC) for people who have never taken HIV medication before. It aims to see if this simpler treatment is effective and safe for controlling HIV-1.
DaejeonAges 19 years+
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hiv?
- Yes. Clin2 currently lists 611 recruiting hiv studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hiv trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hiv trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.